US healthcare reform proposal requires pharma industry to pay $2.3 billion annually
This article was originally published in SRA
Executive Summary
As part of a new healthcare reform proposal, pharma companies in the US would be asked to pay a total of $2.3 billion in annual fees, depending on their market share, starting in 20101.